Chlorhexidine Gluconate (Chlorhexidine Gluconate) Patent Expiration, LOE Window & CMS Spending

Chlorhexidine Gluconate (Chlorhexidine Gluconate) by Bajaj Medical: FDA Orange Book LOE 2027-10-02, 9 AB generics, $13.7M 2024 CMS Part D & Medicaid spend.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorBajaj Medical
FDA Application & PathwayN020111 (NDA)
Exclusivity / Cliff HorizonImmediate Cliff (2025-2027)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2027-10-02
Orange Book Patents (*PED Extensions)2 patents (0 *PED)
Active AB-Rated Generic Competitors9
2024 CMS Total Public Spend$13.7M
2024 Medicare Part D Spend$13.7M
2024 Medicaid Spend$0
Reported Wholesale Price Change (CA SB 17)0 statutory filings in 2023 to 2026 panel